Gene expression studies in systemic lupus erythematosus

Lupus

Volumn 15, Issue 7, 2006, Pages 451-456

  Mandel, M ^a   Achiron, A ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

Autoimmunity; Gene expression; Microarrays; SLE

Indexed keywords

INTERFERON;

ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; DISEASE ACTIVITY; DRUG RESPONSE; GENE EXPRESSION; HUMAN; MEDICAL INFORMATION; MICROARRAY ANALYSIS; PATIENT MONITORING; PHYSICIAN; PRIORITY JOURNAL; PROGNOSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TARGET ORGAN;

AUTOIMMUNITY; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REPRODUCIBILITY OF RESULTS;

EID: 33746597084     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203306lu2332oa     Document Type: Article

References (32)

1. Morrow WJ, Nelson JL, Watts R, Isenberg DA. Autoimmune rheumatic disease, 2nd edition. Oxford University Press, 1999: 56-103.
2. Pisetsky DS. Anti-DNA and autoantibodies. Curr Opin Rheumatol 2000; 12: 364-368.
3. Deapen D, Escalante A, Weinrib L et al. A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum 1992; 35: 311-318.
4. Vyse TJ, Kotzin BL. Genetic susceptibility to systemic lupus erythematosus. Annu Rev Immunol 1998; 16: 261-292.
5. Watson A, Mazumder A, Stewart M, Balasubramanian S. Technology for microarray analysis of gene expression. Curr Opin Biotechnol 1998; 9: 609-614.
6. Yasutomo K. Pathological lymphocyte activation by defective clearance of self-ligands in systemic lupus erythematosus. Rheumatology 2003; 42: 214-222.
7. Kammer GM, Perl A, Richardson BC, Tsokos C. Abnormal T cell signal transduction in systemic lupus erythematosus. Arthrtis Rheum 2003; 46: 1139-1154.
8. Horwitz DA, Stohl W, Gray JD. T lymphocytes, natural killer cells, cytokines, and immune regulation. In Wallace DJ, Hahn BH eds. Dubois' lupus erythematosus, 5th edition. Williams & Wilkins, 1997: 155-160.
9. Linker-Israeli M, Bakke AC, Kitridou RC, Gendler S, Gillis S, Horwitz DA. Defective production of interleukin 1 and 2 in patients with systemic lupus erythematosus. J Immunol 1983; 130: 2651-1655.
10. Tsokos GC. Overview of cellular immune function in systemic lupus erythematosus. In Lahita RG ed. Systemic Lupus Erythematosus, 3rd edition. Academic Press, 1999; 17-20.
11. Whitney AR, Diehn M, Popper SJ et al. Individuality and variation in gene expression patterns in human blood. Proc Natl Acad Sci USA 2003; 100: 1896-1901.
12. Maas K, Chan S, Parker J et al. Cutting edge: molecular portrait of human autoimmune disease. J Immunol 2002; 169: 5-9.
13. Mandel M, Gurevich M, Pauzner R, Kaminski N, Achiron A. Autoimmunity gene expression portrait: specific signature that intersects or differentiates between multiple sclerosis and systemic lupus erythematosus. Clin Exp Immunol 2004; 138: 164-170.
14. Rus V, Atamas SP, Shustova V et al. Expression of cytokine- and chemokine-related genes in peripheral blood mononuclear cells from lupus patients by cDNA array. Clin Immunol 2002; 102: 283-290.
15. Hooks JJ, Moutsopoulos HM, Geis SA, Stahl NI, Decker JL, Notkins AL. Immune interferon in the circulation of patients with autoimmune disease. N Engl J Med 1979; 301: 5-8.
16. Preble OT, Black RJ, Friedman RM, Klippel JH, Vilcek J. Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon. Science 1982; 216: 429-431.
17. Blanco P, Palucka AK, Gill M, Pascual V, Banchereau J. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 2001; 294: 1540-1543.
18. Bennett L, Palucka AK, Arce E et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 2003; 197: 711-723.
19. Baechler EC, Batliwalla FM, Karypis G et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci USA 2003; 100: 2610-2615.
20. Han GM, Chen SL, Shen N, Ye S, Bao CD, Gu YY. Analysis of gene expression profiles in human systemic lupus erythematosus using oligonucleotide microarray. Genes Immun 2003; 4: 177-186.
21. Crow MK, Wohlgemuth J. Microarray analysis of gene expression in lupus. Arthritis Res Ther 2003; 5: 279-287.
22. Crow MK, George S, Paget SA et al. Expression of an interferon-alpha gene program in SLE. Arthritis Rheum 2002; 46: S281.
23. Palucka AK, Blanck JP, Bennett L, Pascual V, Banchereau J. Cross-regulation of TNF and IFN-alpha in autoimmune diseases. Proc Natl Acad Sci USA 2005; 102: 3372-3377.
24. Niewold TB, Swedler WI. Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis C. Clin Rheumatol 2005; 24: 178-181.
25. Kono DH, Baccala R, Theofilopoulos AN. Inhibition of lupus by genetic alteration of the interferon-alpha/beta receptor. Autoimmunity 2003; 36: 503-510.
26. Pereira E, Tamia-Ferreira MC, Cardoso RS et al. Immunosuppressive therapy modulates T lymphocyte gene expression in patients with systemic lupus erythematosus. Immunology 2004; 113: 99-105.
27. Deng YJ, Huang ZX, Zhou CJ et al. Gene profiling involved in immature CD4+ T lymphocyte responsible for systemic lupus erythematosus. Mol Immunol 2006; 43: 1497-1507.
28. Peterson KS, Huang JF, Zhu J et al. Characterization of heterogeneity in the molecular pathogenesis of lupus nephritis from transcriptional profiles of laser-captured glomeruli. J Clin Invest 2004; 113: 1722-1733.
29. Chan RW, Lai FM, Li EK et al. The Effect of immunosuppressive therapy on the messenger RNA expression of target genes in the urinary sediment of patients with active lupus nephritis. Nephrol Dial Transplant 2006; 31 Jan: Epub ahead of print.
30. Manger K, Manger B, Repp R et al. Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus. Ann Rheum Dis 2002; 61: 1065-1070.
31. Rus V, Chen H, Zernetkina V et al. Gene expression profiling in peripheral blood mononuclear cells from lupus patients with active and inactive disease. Clin Immunol 2004; 112: 231-234.
32. Potti A, Bild A, Dressman HK, Lewis DA, Nevins JR, Ortel TL. Gene-expression patterns predict phenotypes of immune-mediated thrombosis. Blood 2006; 107: 1391-1396.